Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Cancer That is…
NCT00043121 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00043121 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery |
| Official title | A Phase I Study of Oxaliplatin, 5-Fluorouracil, and Leucovorin in Combination With Oral Capecitabine in Patients With Advanced Malignancy |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | oxaliplatin, leucovorin calcium, fluorouracil, capecitabine, pharmacological study |
| Enrollment | 50 |
| Start date | Jun 1, 2002 |
| Primary completion | Aug 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: